PUBLIC COMPANY
saveOtsuka Pharmaceutical Co Ltd
updated 2mo ago
Otsuka Pharmaceutical Co., Ltd. , abbreviated OPC, is a pharmaceutical company headquartered in Chiyoda, Tokyo. The company was established on August 10, 1964.
community read0 votes
pipeline
14
marketed
1
phase 3
4
catalysts ytd
1
approvals ytd
1
recalls ytd
0
Pipeline(14)
view full pipeline →pipeline depth14 products
5Phase 11Phase 24Phase 31Marketed2Unknown1pre_registration
Marketed
(cedazuridine + decitabine)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Phase 3delamanid
Pulmonary Tuberculosis
Phase 3quabodepistat
Pulmonary Tuberculosis
Phase 3ulefnersen sodium
Amyotrophic Lateral Sclerosis
Phase 3ulotaront hydrochloride
Generalized Anxiety Disorder (GAD)
Phase 2OPF-310
Type 1 Diabetes (Juvenile Diabetes)
Phase 1CAN-10
Hidradenitis Suppurativa
Phase 1NO-13065
Obesity
Phase 1OPC-214870
Epilepsy
Phase 1SEP-380135
Unspecified Central Nervous System Disorders
Phase 1cedazuridine + decitabine + tolinapant
T-Cell Lymphomas
drugABILIFY MAINTENA KIT
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that